Pure Global AI
Applicant profile

Smith & Nephew Inc. Endoscopy Division

Smith+Nephew
Hong Kong MDACSUnited States10 registered devicesNov 18, 2016 – May 21, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
10
Total devices
3
Risk classes
2016
First registration
2024
Most recent
Applicant overview
Applicant (EN)
Smith & Nephew Inc. Endoscopy Division
Applicant (ZH)
Smith+Nephew
Country
United States
美国
Address
150 Minuteman Road, Andover, Massachusetts, 01810-1031, USA
150 Minuteman Road, 安多弗, 马萨诸塞州, 01810-1031, 美国
Timeline
First registration
Nov 18, 2016
Most recent
May 21, 2024
Regulatory footprint
Search Smith & Nephew Inc. Endoscopy Division across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk class breakdown
II2
III7
IV1
Recent MDACS registrations
Latest 15 devices linked to this applicant
Drill Bits, Surgical, Bone, Cannulated
钻头, 外科, 骨, 空心
May 21, 2024
Risk class
II
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Suture Anchors
缝合锚
Aug 29, 2023
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Sutures, Synthetic, Nonabsorbable, Polyethylene
缝合线, 合成, 非吸收, 聚乙烯
Mar 02, 2023
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Synthetic Ligament Anchors
合成韧带锚
Oct 19, 2021
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Screws, Bone
螺丝,骨头
Oct 18, 2021
Risk class
IV
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Screws, Bone
螺丝,骨头
Apr 07, 2021
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Blades
叶片
Mar 08, 2021
Risk class
II
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Suture Anchors
缝合锚
Feb 22, 2017
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Suture Anchors
缝合锚
Feb 22, 2017
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
Suture Anchors
缝合锚
Nov 18, 2016
Risk class
III
Authorised rep
Smith & Nephew Limited施乐辉有限公司
About this profile

Smith & Nephew Inc. Endoscopy Division is associated with 10 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.